Clinical Trial Update: Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial of sarcosine as preventive therapy for individuals at high risk for schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: Herzog Hospital | Conditions: Schizophrenias, Psychoses | Phase 2 | Status: WITHDRAWN